Chile vs Gabon: Access to anti-retroviral drugs, female
Chile
63.0%
in 2024
Gabon
63.0%
in 2024
Chile rank
96th
Gabon rank
96th
Access to anti-retroviral drugs, female over time
- Chile
- Gabon
How they compare
Chile currently reports 63.0% against 63.0% in Gabon, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Chile ahead.
Chile ranks 96th and Gabon ranks 96th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.7% | 6.9% | 22.8% | Chile |
| 2010s | 56.4% | 36.7% | 19.7% | Chile |
| 2020s | 65.6% | 53.4% | 12.2% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Chile or Gabon?
- Chile, at 63.0% against 63.0% in Gabon as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Chile and Gabon?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Gabon?
- 25 years are reported by both, from 2000 to 2024.
- How do Chile and Gabon rank globally for access to anti-retroviral drugs, female?
- Chile ranks 96th and Gabon ranks 96th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.